CN117838565A - 一种洁面卸妆啫喱及其制备方法 - Google Patents
一种洁面卸妆啫喱及其制备方法 Download PDFInfo
- Publication number
- CN117838565A CN117838565A CN202410037043.0A CN202410037043A CN117838565A CN 117838565 A CN117838565 A CN 117838565A CN 202410037043 A CN202410037043 A CN 202410037043A CN 117838565 A CN117838565 A CN 117838565A
- Authority
- CN
- China
- Prior art keywords
- sodium
- parts
- cleansing
- combination
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title abstract description 17
- 238000001879 gelation Methods 0.000 title description 2
- 239000002562 thickening agent Substances 0.000 claims description 39
- 229940024606 amino acid Drugs 0.000 claims description 33
- 150000001413 amino acids Chemical class 0.000 claims description 33
- 239000002994 raw material Substances 0.000 claims description 28
- 239000004094 surface-active agent Substances 0.000 claims description 28
- 229910052708 sodium Inorganic materials 0.000 claims description 27
- 239000011734 sodium Substances 0.000 claims description 27
- 229940083542 sodium Drugs 0.000 claims description 27
- 238000002156 mixing Methods 0.000 claims description 24
- 239000002280 amphoteric surfactant Substances 0.000 claims description 22
- 239000003945 anionic surfactant Substances 0.000 claims description 22
- 239000002736 nonionic surfactant Substances 0.000 claims description 22
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 20
- 239000004359 castor oil Substances 0.000 claims description 18
- 235000019438 castor oil Nutrition 0.000 claims description 18
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 18
- 230000001815 facial effect Effects 0.000 claims description 17
- -1 methyl taurate Chemical compound 0.000 claims description 15
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 14
- LLRANSBEYQZKFY-UHFFFAOYSA-N dodecanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCCCC(O)=O LLRANSBEYQZKFY-UHFFFAOYSA-N 0.000 claims description 14
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 230000003750 conditioning effect Effects 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- 229920000881 Modified starch Polymers 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 10
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 10
- 239000004519 grease Substances 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 10
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 10
- 229940080352 sodium stearoyl lactylate Drugs 0.000 claims description 9
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 125000005456 glyceride group Chemical group 0.000 claims description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 8
- 239000003755 preservative agent Substances 0.000 claims description 8
- 230000002335 preservative effect Effects 0.000 claims description 8
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 8
- OUNZARDETXBPIX-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)acetic acid Chemical compound CCCCCCCCCCCCOCCOCC(O)=O OUNZARDETXBPIX-UHFFFAOYSA-N 0.000 claims description 7
- 229940105132 myristate Drugs 0.000 claims description 7
- 229940065859 sodium cocoyl glycinate Drugs 0.000 claims description 7
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 claims description 7
- 229940082004 sodium laurate Drugs 0.000 claims description 7
- IKGKWKGYFJBGQJ-UHFFFAOYSA-M sodium;2-(dodecanoylamino)acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCC([O-])=O IKGKWKGYFJBGQJ-UHFFFAOYSA-M 0.000 claims description 7
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 claims description 6
- 229930186217 Glycolipid Natural products 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229940104261 taurate Drugs 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 5
- 150000005846 sugar alcohols Polymers 0.000 claims description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 4
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 claims description 4
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims description 4
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229940073499 decyl glucoside Drugs 0.000 claims description 4
- RLKBYNBLYZHLNH-UHFFFAOYSA-N dodecyl 2-hydroxyacetate;sodium Chemical compound [Na].CCCCCCCCCCCCOC(=O)CO RLKBYNBLYZHLNH-UHFFFAOYSA-N 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 229930182478 glucoside Natural products 0.000 claims description 4
- 229960005323 phenoxyethanol Drugs 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims description 3
- 229940080421 coco glucoside Drugs 0.000 claims description 3
- 229940079868 disodium laureth sulfosuccinate Drugs 0.000 claims description 3
- YGAXLGGEEQLLKV-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-2-sulfonatobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)CC(C([O-])=O)S([O-])(=O)=O YGAXLGGEEQLLKV-UHFFFAOYSA-L 0.000 claims description 3
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 claims description 3
- 229940048848 lauryl glucoside Drugs 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 229920005862 polyol Polymers 0.000 claims description 3
- 150000003077 polyols Chemical class 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 2
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 claims description 2
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 2
- 229940035437 1,3-propanediol Drugs 0.000 claims description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000001534 FEMA 4201 Substances 0.000 claims description 2
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- DUFKCOQISQKSAV-UHFFFAOYSA-N Polypropylene glycol (m w 1,200-3,000) Chemical compound CC(O)COC(C)CO DUFKCOQISQKSAV-UHFFFAOYSA-N 0.000 claims description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 2
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 claims description 2
- ZPVGIKNDGJGLCO-VGAMQAOUSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZPVGIKNDGJGLCO-VGAMQAOUSA-N 0.000 claims description 2
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 claims description 2
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 claims description 2
- 229940071124 cocoyl glutamate Drugs 0.000 claims description 2
- 229940119676 diethoxyethyl succinate Drugs 0.000 claims description 2
- WWYHAQDAMPXWSI-UHFFFAOYSA-N dodecan-1-ol;methane Chemical compound C.CCCCCCCCCCCCO WWYHAQDAMPXWSI-UHFFFAOYSA-N 0.000 claims description 2
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- NIDYWHLDTIVRJT-UJPOAAIJSA-N heptyl-β-d-glucopyranoside Chemical compound CCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NIDYWHLDTIVRJT-UJPOAAIJSA-N 0.000 claims description 2
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 claims description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 2
- 229940094506 lauryl betaine Drugs 0.000 claims description 2
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 claims description 2
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 claims description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- VWMVAQHMFFZQGD-UHFFFAOYSA-N p-Hydroxybenzyl acetone Natural products CC(=O)CC1=CC=C(O)C=C1 VWMVAQHMFFZQGD-UHFFFAOYSA-N 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 229940116406 poloxamer 184 Drugs 0.000 claims description 2
- 229920001993 poloxamer 188 Polymers 0.000 claims description 2
- 229940044519 poloxamer 188 Drugs 0.000 claims description 2
- 229940094541 polyglycerin-10 Drugs 0.000 claims description 2
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 claims description 2
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 claims description 2
- 229950008882 polysorbate Drugs 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 2
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 claims description 2
- NJGBTKGETPDVIK-UHFFFAOYSA-N raspberry ketone Chemical compound CC(=O)CCC1=CC=C(O)C=C1 NJGBTKGETPDVIK-UHFFFAOYSA-N 0.000 claims description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 2
- 229940031688 sodium c14-16 olefin sulfonate Drugs 0.000 claims description 2
- 229940079776 sodium cocoyl isethionate Drugs 0.000 claims description 2
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 claims description 2
- 229950006451 sorbitan laurate Drugs 0.000 claims description 2
- 235000011067 sorbitan monolaureate Nutrition 0.000 claims description 2
- 229950002441 glucurolactone Drugs 0.000 claims 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229940050410 gluconate Drugs 0.000 claims 1
- 150000008131 glucosides Chemical class 0.000 claims 1
- 235000014593 oils and fats Nutrition 0.000 claims 1
- 238000004140 cleaning Methods 0.000 abstract description 12
- 239000006260 foam Substances 0.000 abstract description 10
- 239000002537 cosmetic Substances 0.000 abstract description 9
- 238000005406 washing Methods 0.000 abstract description 8
- 239000004973 liquid crystal related substance Substances 0.000 abstract description 7
- 230000037072 sun protection Effects 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 description 31
- 235000001014 amino acid Nutrition 0.000 description 28
- 239000000047 product Substances 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 14
- 230000003020 moisturizing effect Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 6
- 238000005187 foaming Methods 0.000 description 6
- 239000000516 sunscreening agent Substances 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 5
- 206010040880 Skin irritation Diseases 0.000 description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000004922 Vigna radiata Species 0.000 description 3
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 3
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000037307 sensitive skin Effects 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- BCISDMIQYBCHAT-UHFFFAOYSA-M sodium;2-(dodecanoylamino)ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCCS([O-])(=O)=O BCISDMIQYBCHAT-UHFFFAOYSA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- CCLARULDIPFTCP-BOYHRMMASA-N (2r,3r,4r,5s)-heptane-1,2,3,4,5,6-hexol Chemical compound CC(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO CCLARULDIPFTCP-BOYHRMMASA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229940045790 sodium lauryl glycol carboxylate Drugs 0.000 description 2
- UIGBPGNEWMRLGK-UHFFFAOYSA-M sodium;2-(2-hydroxydodecoxy)acetate Chemical compound [Na+].CCCCCCCCCCC(O)COCC([O-])=O UIGBPGNEWMRLGK-UHFFFAOYSA-M 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KZVAAIRBJJYZOW-VPENINKCSA-N (2r,3r,4s)-2-(hydroxymethyl)oxolane-3,4-diol Chemical compound OC[C@H]1OC[C@H](O)[C@H]1O KZVAAIRBJJYZOW-VPENINKCSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 244000302661 Phyllostachys pubescens Species 0.000 description 1
- 235000003570 Phyllostachys pubescens Nutrition 0.000 description 1
- 241000218689 Podocarpus Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 1
- 229940069638 aloe vera leaf extract Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229940083987 anhydroxylitol Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960004580 glibenclamide Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- 239000004247 glycine and its sodium salt Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940071145 lauroyl sarcosinate Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 229940029258 sodium glycinate Drugs 0.000 description 1
- WUWHFEHKUQVYLF-UHFFFAOYSA-M sodium;2-aminoacetate Chemical compound [Na+].NCC([O-])=O WUWHFEHKUQVYLF-UHFFFAOYSA-M 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 229940098386 usnea barbata extract Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/14—Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
本发明提供一种洁面卸妆啫喱及其制备方法,所述洁面卸妆啫喱的原料包括多元醇、增稠剂、油脂类、氨基酸表面活性剂、两性表面活性剂、阴离子表面活性剂、非离子表面活性剂和皮肤调理剂。本发明提供的洁面卸妆二合一啫喱,泡沫丰富且绵密,温和不刺激,可以有效清除彩妆和防晒,洁面卸妆啫喱具有的液晶结构稳定,在不过度清洁皮肤的同时可以保持面部水油平衡,洗后肤感舒爽。
Description
技术领域
本发明属于日化用品技术领域,具体涉及一种洁面卸妆啫喱及其制备方法。
背景技术
目前市面上有卸妆洁面二合一的产品,但是都会存在泡沫量少、卸妆能力较弱以及洗后肤感滑涩等,缺乏一款较为综合的卸妆洁面型产品。若长期卸妆不干净有残留累积的话,面部皮肤的毛孔会粗大,黑头数目增多,且皮肤会越来越粗糙暗黄,堵塞毛孔,导致皮肤红肿过敏长痘,炎症加剧而导致面部衰老;而过度的清洁则会导致皮肤酸碱失衡,皮肤的脂质过度流失,破坏皮肤屏障,造成肌肤敏感,毛孔粗大的问题。因此需要开发一款洁面卸妆二合一的产品,既能有效卸除脸上彩妆以及防晒以外,还能不过度清洁肌肤,保持面部的水油平衡,呈现肌肤的健康状态。
一些干性、中性、敏感肌肤的人需要保湿效果较好的洁面啫喱,但是目前的洁面啫喱大多只是具有洁面的效果,而不具有净化肌肤和修复敏感肌肤的功效,现代女性大多化妆,如果所用的洁面啫喱卸妆效果不佳也会对皮肤产生影响。
CN105832649A公开了一种绿豆酵素净颜洁面啫喱,该绿豆酵素净颜洁面啫喱包括如下重量百分比的组份:烷醇丙烯酸酯交联聚合物0.8-1.2,乳酸菌或绿豆籽提取物发酵产物滤液20-30,EDTA二纳0.05-0.1,库拉索芦荟叶提取物0.3-0.5,海藻糖1-3,30%月桂酰肌氨酸钠2-6,霍霍巴蜡PEG-120酯类1-3,丁二醇1-5,须松萝提取物0.01-0.05,氯苯甘醚0.1-0.3,罗汉松提取物0.5-2,1.3丙二醇0.8-1.5,PEG-40氢化蓖麻油1-4,橄榄油PEG-7酯类1-4,椰油基葡糖苷1-5,水2-4,脱乙酰壳多糖单琥珀酰胺2-5,10%氢氧化钾,5%修护中药提取物余量。该绿豆酵素净颜洁面啫喱,温和清洁、卸妆、修复敏感皮肤,净化肌肤,祛痘修复。
CN106474015A公开了一种长效保湿的功效性洁面啫喱,由以下重量份的原料构成:水85-90重量份,清洁剂6-10重量份,增稠剂1-3重量份,保湿剂1-2重量份,乳化剂0.3-0.8重量份,皮肤调理剂0.15-0.25重量份,植物成分提取物0.15-0.25重量份,螯合剂0.03-0.08重量份,着色剂0.005-0.015重量份。该洁面啫喱中含有龙头竹提取物及其他植物成分提取物,细腻丰盈的泡沫由内而外温和而彻底地清洁面部肌肤,令肌肤倍感舒爽健康,瞬间焕然一新,清洁同时补充干涩肌肤水分,润泽肌肤,是一种具有长效保湿的功效性护肤品。
氨基酸表面活性剂的粘度随温度变化非常大,存放一段时间后,产品可能出现泛粗、出水等缺陷。
CN111514062A公开了一种液晶型氨基酸洗面奶,所述组分及各组分的重量百分比是:椰油酰甘氨酸钠15~18份,月桂酰肌氨酸钠/月桂酰谷氨酸钠20~25份,改性玉米淀粉3~5份,甘油15~18份,丙烯酸类共聚物2.5~4份,硬脂酸1.5~2份,柠檬酸钠3~5份,珠光双酯2~2.5份,液晶增稠剂(月桂酸牛磺酸钠/改性玉米淀粉/月桂酸/肉豆蔻酸)22~25份,苯氧乙醇0.3~0.6份,其余为水。该液晶型氨基酸洗面奶采用苯氧乙醇作为防腐剂,没有添加香精和色素,性质温和,不会引起皮肤过敏和刺激,配方的PH呈弱酸性,泡沫细腻丰富易清洗,清洁效果好。且本发明所述的配方工艺简单,便于生产。
因此,开发一种洁面卸妆二合一啫喱,在有效卸除彩妆的同时还可以保持面部的水油平衡,泡沫丰富,有效保湿,是本领域的研究重点。
发明内容
针对现有技术的不足,本发明的目的在于提供一种洁面卸妆啫喱及其制备方法,在有效卸除彩妆的同时还可以保持面部的水油平衡,泡沫丰富,有效保湿。
为达到此发明目的,本发明采用以下技术方案:
第一方面,本发明提供一种洁面卸妆啫喱,所述洁面卸妆啫喱的原料包括:多元醇、增稠剂、油脂类、氨基酸表面活性剂、两性表面活性剂、阴离子表面活性剂、非离子表面活性剂和皮肤调理剂。
优选地,以重量份数计,所述洁面卸妆啫喱的原料包括:多元醇10-30份(例如可以为12份、14份、16份、18份、20份、22份、24份、26份、28份等)、增稠剂5-20份(例如可以为6份、8份、10份、12份、14份、16份、18份等)、油脂类1-5份(例如可以为2份、3份、4份等)、氨基酸表面活性剂10-30份(例如可以为10份、12份、14份、16份、18份、20份、22份、24份、26份、28份等)、两性表面活性剂2-10份(例如可以为4份、6份、8份等)、阴离子表面活性剂2-10份(例如可以为4份、6份、8份等)、非离子表面活性剂0.5-5份(例如可以为0.6份、0.8份、1份、1.2份、1.4份、1.6份、1.8份、2份、3份、4份等)、皮肤调理剂0.5-3份(例如可以为0.6份、0.8份、1份、1.5份、2份、2.5份等)。
优选地,所述多元醇包括甘油、丁二醇、1,3-丙二醇或双丙甘醇中的任意一种或至少两种的组合。
优选地,所述增稠剂为增稠剂I和增稠剂II的组合。
优选地,所述增稠剂I与增稠剂II的质量比为(3-5):1,例如可以为3.5:1、4:1、4.5:1等。
优选地,所述增稠剂I包括改性玉米淀粉、椰油酰基氨基酸钠和月桂酸牛磺酸钠。
优选地,所述增稠剂II包括月桂醇硫酸酯钠、硬脂酰乳酰乳酸钠和氢化蓖麻油。
本发明采用上述两种增稠剂的组合,可以避免现有技术中采用高分子增稠剂产生的黏腻感,难起泡和洗后滑涩的问题,一定程度上增加了洁面产品的发泡速度,同时洗后湿润不干涩。
优选地,所述油脂类包括PPG-3辛基醚、琥珀酸二乙氧基乙酯、丙二醇月桂酸酯或异壬酸异壬酯中的任意一种或至少两种的组合。
优选地,所述油脂类为丙二醇月桂酸酯和异壬酸异壬酯的组合。
优选地,所述丙二醇月桂酸酯和异壬酸异壬酯的质量比为(0.8-1.2):1,例如可以为0.9:1、1:1、1.1:1等。
优选地,所述氨基酸表面活性剂包括椰油酰甘氨酸钠和椰油酰基谷氨酸TEA盐的组合或椰油酰甘氨酸钠和椰油酰水解燕麦蛋白钾的组合。
优选地,所述两性表面活性剂包括月桂酰两性基乙酸钠、椰油酰两性基乙酸钠、椰油酰两性基二乙酸二钠、月桂基甜菜碱、椰油基甜菜碱、椰油酰两性基羟丙基磺酸钠、椰油酰胺丙基甜菜碱、椰油酰胺丙基羟基磺基甜菜碱或月桂基羟基磺基甜菜碱中的任意一种或至少两种的组合。
优选地,所述两性表面活性剂为月桂酰两性基乙酸钠和月桂基羟基磺基甜菜碱的组合。
优选地,所述阴离子表面活性剂包括月桂醇聚醚磺基琥珀酸酯二钠、甲基椰油酰基牛磺酸钠、椰油酰甲基牛磺酸牛磺酸钠、椰油酰氨基丙酸钠、C14-16烯烃磺酸钠、月桂基甘醇羧酸钠、月桂醇聚醚-6羧酸钠、月桂醇磷酸酯钾、椰油酰羟乙磺酸酯钠或月桂基葡萄糖羧酸钠中的任意一种或至少两种的组合。
优选地,所述阴离子表面活性剂为月桂基甘醇羧酸钠和月桂醇聚醚-6羧酸钠的组合。
优选地,所述非离子表面活性剂包括糖脂、癸基葡糖苷、辛基/癸基葡糖苷、月桂基葡糖苷、椰油基葡糖苷、庚基葡糖苷、泊洛沙姆184、泊洛沙姆188、PEG-6辛酸/癸酸甘油酯类、PEG-7辛酸/癸酸甘油酯类、PEG-8辛酸/癸酸甘油酯类、PEG-7甘油椰油酸酯、PEG-80失水山梨醇月桂酸酯、蔗糖月桂酸酯、蔗糖二月桂酸酯、蔗糖棕榈酸酯、蔗糖硬脂酸酯、蔗糖多硬脂酸酯、聚甘油-2癸酸酯、聚甘油-3癸酸酯、聚甘油-4癸酸酯、聚甘油-6辛酸酯、辛酸/癸酸甘油酯类聚甘油-10酯类、聚甘油-10月桂酸酯、聚甘油-10肉豆蔻酸酯、聚甘油-10油酸酯或聚甘油-10硬脂酸酯中的任意一种或至少两种的组合;
优选地,所述非离子表面活性剂为糖脂和聚甘油-10肉豆蔻酸酯的组合。
优选地,所述皮肤调理剂包括氢化淀粉水解物、麦芽寡糖葡糖苷、木糖醇基葡糖苷、木糖醇、脱水木糖醇、PPG-10甲基葡糖醚、甲基葡糖醇聚醚-10、甲基葡糖醇聚醚-20、甘油葡糖苷、聚季铵盐-7、聚季铵盐-22、聚季铵盐-39、透明质酸钠、马来酸改性蓖麻油或C12-13醇乳酸酯中的任意一种或至少两种的组合。
优选地,所述皮肤调理剂为PPG-10甲基葡糖醚、聚季铵盐-7和马来酸改性蓖麻油的组合。
优选地,所述洁面卸妆啫喱中还包括防腐剂。
优选地,所述防腐剂包括1,2-己二醇、1,2-戊二醇、对羟基苯乙酮、覆盆子酮、苯氧乙醇、乙基己基甘油或辛甘醇中的任意一种或至少两种的组合。
第二方面,本发明提供一种如第一方面所述的洁面卸妆啫喱的制备方法,所述制备方法包括如下步骤:
(1)将多元醇、氨基酸表面活性剂、两性表面活性剂、阴离子表面活性剂、非离子表面活性剂和水混合均匀,得到混合物;
(2)将所述混合物加热搅拌,分批次加入增稠剂,继续搅拌至分散均匀,降温加入皮肤调理剂、可选地防腐剂,搅拌均匀,过滤,得到所述洁面卸妆啫喱。
优选地,步骤(2)中加热搅拌的温度为90-95℃,例如可以为91℃、92℃、93℃、94℃等。
优选地,所述降温的温度为45-50℃,例如可以为46℃、47℃、48℃、49℃等。
优选地,所述过滤的滤布孔径为80-120目,例如可以为90目、100目、110目等。
本发明所述的数值范围不仅包括上述列举的点值,还包括没有列举出的上述数值范围之间的任意的点值,限于篇幅及出于简明的考虑,本发明不再穷尽列举所述范围包括的具体点值。
相对于现有技术,本发明具有以下有益效果:
1、本发明提供的洁面卸妆二合一啫喱,泡沫丰富且绵密,温和不刺激,可以有效清除彩妆和防晒,洁面卸妆啫喱液晶结构稳定,在不过度清洁皮肤的同时可以保持面部水油平衡,洗后肤感舒爽。
2、本发明洁面卸妆啫喱中采用的油脂为丙二醇月桂酸酯和异壬酸异壬酯的搭配,两者协同作用共同促进洁面卸妆啫喱清除彩妆,并且保证洁面后的保湿效果。
3、本发明将氨基酸表面活性剂、两性表面活性剂、阴离子表面活性剂和非离子表面活性剂四种表活进行搭配使用,共同促进洁面卸妆啫喱的清洁功效,并且可以增加使用后的保湿感。
4、本发明的增稠剂采用两种组合搭配,有效避免现有技术中采用高分子增稠剂产生的黏腻感,难起泡和洗后滑涩的问题,一定程度上增加了洁面产品的发泡速度,同时洗后水润舒爽。
附图说明
图1为实施例1中的洁面卸妆啫喱的液晶结构放大图;
图2为受试者采用实施例1对防晒霜(高姿柔皙透白精华防晒霜)擦拭前后的皮肤对比图;
图3为受试者采用实施例1对防晒乳(薇诺娜清透防晒乳)擦拭前后的皮肤对比图;
图4为受试者采用实施例1对防晒乳(安热沙金灿倍护防晒乳)擦拭前后的皮肤对比图;
图5为受试者采用实施例1对隔离粉底(欧莱雅多重防护隔离露)擦拭前后的皮肤对比图。
具体实施方式
下面通过具体实施方式来进一步说明本发明的技术方案。本领域技术人员应该明了,所述实施例仅仅是帮助理解本发明,不应视为对本发明的具体限制。
本文所用术语“包含”、“包括”、“具有”、“含有”或其任何其它变形,意在覆盖非排它性的包括。例如,包含所列要素的组合物、步骤、方法、制品或装置不必仅限于那些要素,还可包括未明确列出的其它要素或此种组合物、步骤、方法、制品或装置所固有的要素。
“任选的”或者“任意一种”是指其后描述的事项或事件可以发生或不发生,而且该描述包括事件发生的情形和事件不发生的情形。
本发明要素或组分前的不定冠词“一种”和“一个”对要素或组分的数量要求(即出现次数)无限制性。因此“一个”或“一种”应被解读为包括一个或至少一个,并且单数形式的要素或组分也包括复数形式,除非所述数量明显只指单数形式。
本发明所描述的术语“一个实施例”、“一些实施例”、“示例性地”、“具体示例”或“一些示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本文中,对上述术语的示意性表述不是必须针对相同的实施例或示例。
本发明中,除非另有其他明确说明,否则百分比、百分含量均以质量计。如无特殊说明,所使用的实验方法均为常规方法,所用材料、试剂等均可从商业途径购买。
下述实施例、对比例中所涉及的原料的规格信息如下:
实施例1
本实施例提供一种洁面卸妆啫喱,所述洁面卸妆啫喱的原料包括:甘油25份、增稠剂15份、油脂类3份、氨基酸表面活性剂16份、两性表面活性剂6份、阴离子表面活性剂6份、非离子表面活性剂1份、皮肤调理剂2份、对羟基苯乙酮1份,余量为水(共100份);
所述增稠剂为(改性玉米淀粉&椰油酰基氨基酸钠&月桂酸牛磺酸钠)和(月桂醇硫酸酯钠&硬脂酰乳酰乳酸钠&氢化蓖麻油)按照质量比4:1混合得到;
所述油脂类为丙二醇月桂酸酯和异壬酸异壬酯按照质量比1:1混合得到;
所述氨基酸表面活性剂为椰油酰甘氨酸钠和椰油酰基谷氨酸TEA盐按照质量比2:1混合得到;
所述两性表面活性剂为月桂酰两性基乙酸钠和月桂基羟基磺基甜菜碱按照质量比1:1混合得到;
所述阴离子表面活性剂为月桂基甘醇羧酸钠和月桂醇聚醚-6羧酸钠按照质量比1:1.5混合得到;
所述非离子表面活性剂为糖脂和聚甘油-10肉豆蔻酸酯按照质量比1:1.5混合得到;
所述皮肤调理剂为PPG-10甲基葡糖醚、聚季铵盐-7和马来酸改性蓖麻油按照质量比1:1.5:1混合得到;
制备方法如下:
(1)将多元醇、氨基酸表面活性剂、两性表面活性剂、阴离子表面活性剂、非离子表面活性剂和水混合均匀,得到混合物;
(2)将所述混合物95℃加热搅拌,分批次加入增稠剂,继续搅拌至分散均匀,降温至45℃加入皮肤调理剂、防腐剂,搅拌均匀,过滤,得到所述洁面卸妆啫喱。
针对实施例1中的洁面卸妆啫喱进行了液晶结构检测,使用LABOMED光学电子显微镜观察,放大400倍后,获得的液晶结构图如图1所示。
实施例2
本实施例提供一种洁面卸妆啫喱,所述洁面卸妆啫喱的原料包括:丁二醇30份、增稠剂20份、油脂类1份、氨基酸表面活性剂30份、两性表面活性剂2份、阴离子表面活性剂2份、非离子表面活性剂5份、皮肤调理剂0.5份、对羟基苯乙酮1份,余量为水(共100份);
所述增稠剂为(改性玉米淀粉&椰油酰基氨基酸钠&月桂酸牛磺酸钠)和(月桂醇硫酸酯钠&硬脂酰乳酰乳酸钠&氢化蓖麻油)按照质量比3:1混合得到;
所述油脂类为丙二醇月桂酸酯和异壬酸异壬酯按照质量比0.8:1混合得到;
所述氨基酸表面活性剂为椰油酰甘氨酸钠和椰油酰水解燕麦蛋白钾按照质量比1:2混合得到;
所述两性表面活性剂为月桂酰两性基乙酸钠和月桂基羟基磺基甜菜碱按照质量比2:1混合得到;
所述阴离子表面活性剂为月桂基甘醇羧酸钠和月桂醇聚醚-6羧酸钠按照质量比2:1混合得到;
所述非离子表面活性剂为糖脂和聚甘油-10肉豆蔻酸酯按照质量比2:1混合得到;
所述皮肤调理剂为PPG-10甲基葡糖醚、聚季铵盐-7和马来酸改性蓖麻油按照质量比2:1:2混合得到;
制备方法参照实施例1。
实施例3
本实施例提供一种洁面卸妆啫喱,所述洁面卸妆啫喱的原料包括:丁二醇10份、增稠剂5份、油脂类5份、氨基酸表面活性剂10份、两性表面活性剂10份、阴离子表面活性剂10份、非离子表面活性剂0.5份、皮肤调理剂3份、对羟基苯乙酮1份,余量为水(共100份);
所述增稠剂为(改性玉米淀粉&椰油酰基氨基酸钠&月桂酸牛磺酸钠)和(月桂醇硫酸酯钠&硬脂酰乳酰乳酸钠&氢化蓖麻油)按照质量比5:1混合得到;
所述油脂类为丙二醇月桂酸酯和异壬酸异壬酯按照质量比1.2:1混合得到;
所述氨基酸表面活性剂为椰油酰甘氨酸钠和椰油酰水解燕麦蛋白钾按照质量比2:1混合得到;
所述两性表面活性剂为椰油酰两性基乙酸钠和椰油酰胺丙基甜菜碱按照质量比1:2混合得到;
所述阴离子表面活性剂为月桂醇聚醚磺基琥珀酸酯二钠和月桂醇聚醚-6羧酸钠按照质量比1:1混合得到;
所述非离子表面活性剂为月桂基葡糖苷和聚甘油-10肉豆蔻酸酯按照质量比1:2混合得到;
所述皮肤调理剂为透明质酸钠、聚季铵盐-7和马来酸改性蓖麻油按照质量比2:1:1混合得到;
制备方法参照实施例1。
实施例4
本实施例提供一种洁面卸妆啫喱,其与实施例1的区别仅在于调整增稠剂仅为(改性玉米淀粉&椰油酰基氨基酸钠&月桂酸牛磺酸钠),添加量为15份;其他原料、原料和制备方法均参照实施例1。
实施例5
本实施例提供一种洁面卸妆啫喱,其与实施例1的区别仅在于调整增稠剂仅为(月桂醇硫酸酯钠&硬脂酰乳酰乳酸钠&氢化蓖麻油),添加量为15份;其他原料、原料和制备方法均参照实施例1。
实施例6
本实施例提供一种洁面卸妆啫喱,其与实施例1的区别仅在于调整增稠剂中(改性玉米淀粉&椰油酰基氨基酸钠&月桂酸牛磺酸钠)和(月桂醇硫酸酯钠&氢化蓖麻油)的质量比为1:4;其他原料、原料和制备方法均参照实施例1。
实施例7
本实施例提供一种洁面卸妆啫喱,其与实施例1的区别仅在于调整油脂类为丙二醇月桂酸酯,未加入异壬酸异壬酯;其他原料、原料和制备方法均参照实施例1。
实施例8
本实施例提供一种洁面卸妆啫喱,其与实施例1的区别仅在于调整油脂类为异壬酸异壬酯,未加入丙二醇月桂酸酯;其他原料、原料和制备方法均参照实施例1。
对比例1
本对比例提供一种洁面卸妆啫喱,其与实施例1的区别仅在于未加入氨基酸表面活性剂,在保持四种表面活性剂总量不变的情况下,不足的部分由两性表面活性剂、阴离子表面活性剂和非离子表面活性剂按照6:6:1的比例补足;其他原料、原料和制备方法均参照实施例1。
对比例2
本对比例提供一种洁面卸妆啫喱,其与实施例1的区别仅在于未加入两性表面活性剂,在保持四种表面活性剂总量不变的情况下,不足的部分由氨基酸表面活性剂、阴离子表面活性剂和非离子表面活性剂按照16:6:1的比例补足;其他原料、原料和制备方法均参照实施例1。
对比例3
本对比例提供一种洁面卸妆啫喱,其与实施例1的区别仅在于未加入阴离子表面活性剂,在保持四种表面活性剂总量不变的情况下,不足的部分由氨基酸表面活性剂、两性表面活性剂和非离子表面活性剂按照16:6:1的比例补足;其他原料、原料和制备方法均参照实施例1。
对比例4
本对比例提供一种洁面卸妆啫喱,其与实施例1的区别仅在于未加入非离子表面活性剂,在保持四种表面活性剂总量不变的情况下,不足的部分由氨基酸表面活性剂、两性表面活性剂和阴离子表面活性剂按照16:6:6的比例补足;其他原料、原料和制备方法均参照实施例1。
测试例1
急性皮肤刺激性试验
受试动物为日本大耳白兔,雄性,共25,动物于普通环境动物房适应3d,完成动物检疫,确认动物健康后开展试验。受试物为实施例、对比例制备的洁面卸妆啫喱;
试验方法:
①试验前24h,将动物背部脊柱两侧毛剔除,不得损伤皮肤。去毛范围左右各3cm×3cm。
②染毒方法:取受试物0.5mL涂在左侧皮肤上,涂抹范围约2.5cm×2.5cm,然后用二层纱布(2.5cm×2.5cm)和一层玻璃纸覆盖,再用无刺激性胶布加以固定。另一侧皮肤作为空白对照。该受试物采用封闭试验,敷用时间为2h。试验结束后,用温水除去残留受试物。分别去除受试物1h、12h观察涂抹部位皮肤反应。
③结果评价:按照按《化妆品安全技术规范》(2015年版)第六章毒理学试验方法4皮肤刺激性/腐蚀性试验进行评分,并根据1h、12h各个观察时间点最高积分均值,判定皮肤刺激强度。结果如表1所示。表1
根据表格数据可知,本发明提供的洁面卸妆啫喱温和、不刺激,急性皮肤刺激性等级为无刺激,安全可靠,可以适用于敏感肌。
测试例2
卸妆能力测试
取实施例、对比例制备的洁面卸妆啫喱和市售某卸妆啫喱进行卸妆效果评估。测试方法:安排20名年龄25-55岁身体健康成年人,根据随机表在前手臂内侧的4个面积大小相同的区域(3×3cm)分别均匀涂抹等量的口红、粉底、防晒,5min后分别将50mg的实施例、对比例制备的洁面卸妆啫喱、市售卸妆啫喱置于对应的测试区域,采用同一品牌的卸妆棉沾取试验样品和对照样品,分别敷在手臂涂有不同化妆品的位置上5s,然后朝向相同方向擦拭,更换化妆棉重复擦拭步骤,直至化妆棉上没有颜色,记录擦拭的次数以及化妆品残留情况。
试验结果:受试者卸妆擦拭的次数平均值如表2所示。
示例性地,受试者采用实施例1对防晒霜(高姿柔皙透白精华防晒霜)擦拭前后的皮肤对比图如图2所示;
受试者采用实施例1对防晒乳(薇诺娜清透防晒乳)擦拭前后的皮肤对比图如图3所示;
受试者采用实施例1对防晒乳(安热沙金灿倍护防晒乳)擦拭前后的皮肤对比图如图4所示;
受试者采用实施例1对隔离粉底(欧莱雅多重防护隔离露)擦拭前后的皮肤对比图如图5所示。
测试例3
皮肤水分流失率
使用水分流失探头Tewameter TM300(德国CK公司)进行测试;测试受试者脸颊,量取三次取平均值,皮肤水分流失变化率的数值越低、绝对值越大,说明样品对皮肤的屏障功能和修复能力改善效果越好;
选取40名年龄在30-50岁的健康受试者,随机分成7组,每组10人,男女不限。受试者测试当天早上不可以使用任何化妆品。用清水清洁完面部后,在温度21.0℃±1.0℃,湿度50%±5%的恒温恒湿间休息30min,30min后,对面部进行仪器测试,记录皮肤的初始数值。测试完成后对受试者进行使用说明,每天取0.5g应用例和对比应用例制备的洁面卸妆啫喱放在手心上加少量水溶解后,再揉搓出泡沫后进行面部清洁,每日早晚使用,一周后进行回访,测试受试者使用实验样品一周后的参数。测试结果如表2所示。
表2
测试例4
消费者使用的喜好度
分发样品给30名消费者回家进行测试,测试产品的泡沫以及使用的喜好度,综合产品的起泡速度、泡沫量、洗后保湿感、香味维度综合评分,每次用量为0.5g,早晚各使用一次,评分为1-5分,1分为不喜欢,2分为勉强接受,3分为一般,4分为较满意,5分为十分满意。
表3
根据测试例2-4的表格数据可知,当采用(改性玉米淀粉&椰油酰基氨基酸钠&月桂酸牛磺酸钠)和(月桂醇硫酸酯钠&硬脂酰乳酰乳酸钠&氢化蓖麻油)的组合作为增稠剂时,当其总添加量为15%,质量比为4:1时,卸妆和保湿效果最佳,缺少任何一种组合,均会受到不利影响;由实施例1-3可知,当增稠剂总添加量为5%时,产品的卸妆和保湿能力较15%差,当总添加量为20%时,产品稠度会高一些,起泡速度和膏体化开的速度会慢一些,影响用户使用的喜好度,且产品的卸妆能力变化不大,并且(改性玉米淀粉&椰油酰基氨基酸钠&月桂酸牛磺酸钠)和(月桂醇硫酸酯钠&硬脂酰乳酰乳酸钠&氢化蓖麻油)的质量比为(3-5):1时,卸妆效果、保湿效果均优;由实施例1-3、实施例6可知,当增稠剂中(月桂醇硫酸酯钠&硬脂酰乳酰乳酸钠&氢化蓖麻油)的比例过高时,会影响卸妆能力。
由实施例1、实施例7-8可知,当采用丙二醇月桂酸酯和异壬酸异壬酯搭配作为油脂使用时,可以保证妆溶性和保湿性,缺少其中任意一种组分,卸妆和保湿效果将大幅度下降;由实施例1、对比例1-4可知,本发明采用氨基酸表面活性剂、两性表面活性剂、阴离子表面活性剂和非离子表面活性剂四种表活进行搭配使用,共同促进洁面卸妆啫喱的清洁功效和保湿功效,缺少任意一种表活,清洁能力均为大幅度下降。
申请人声明,本发明通过上述实施例来说明本发明的工艺方法,但本发明并不局限于上述工艺步骤,即不意味着本发明必须依赖上述工艺步骤才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明所选用原料的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。
以上详细描述了本发明的优选实施方式,但是,本发明并不限于上述实施方式中的具体细节,在本发明的技术构思范围内,可以对本发明的技术方案进行多种简单变型,这些简单变型均属于本发明的保护范围。
另外需要说明的是,在上述具体实施方式中所描述的各个具体技术特征,在不矛盾的情况下,可以通过任何合适的方式进行组合,为了避免不必要的重复,本发明对各种可能的组合方式不再另行说明。
Claims (10)
1.一种洁面卸妆啫喱,其特征在于,所述洁面卸妆啫喱的原料包括:多元醇、增稠剂、油脂类、氨基酸表面活性剂、两性表面活性剂、阴离子表面活性剂、非离子表面活性剂和皮肤调理剂。
2.根据权利要求1所述的洁面卸妆啫喱,其特征在于,以重量份数计,所述洁面卸妆啫喱的原料包括:多元醇10-30份、增稠剂5-20份、油脂类1-5份、氨基酸表面活性剂10-30份、两性表面活性剂2-10份、阴离子表面活性剂2-10份、非离子表面活性剂0.5-5份、皮肤调理剂0.5-3份。
3.根据权利要求1或2所述的洁面卸妆啫喱,其特征在于,所述多元醇包括甘油、丁二醇、1,3-丙二醇或双丙甘醇中的任意一种或至少两种的组合;
优选地,所述增稠剂为增稠剂I和增稠剂II的组合;
优选地,所述增稠剂I与增稠剂II的质量比为(3-5):1;
优选地,所述增稠剂I包括改性玉米淀粉、椰油酰基氨基酸钠和月桂酸牛磺酸钠;
优选地,所述增稠剂II包括月桂醇硫酸酯钠、硬脂酰乳酰乳酸钠和氢化蓖麻油。
4.根据权利要求1-3任一项所述的洁面卸妆啫喱,其特征在于,所述油脂类包括PPG-3辛基醚、琥珀酸二乙氧基乙酯、丙二醇月桂酸酯或异壬酸异壬酯中的任意一种或至少两种的组合;
优选地,所述油脂类为丙二醇月桂酸酯和异壬酸异壬酯的组合;
优选地,所述丙二醇月桂酸酯和异壬酸异壬酯的质量比为(0.8-1.2):1。
5.根据权利要求1-4任一项所述的洁面卸妆啫喱,其特征在于,所述氨基酸表面活性剂包括椰油酰甘氨酸钠和椰油酰基谷氨酸TEA盐的组合或椰油酰甘氨酸钠和椰油酰水解燕麦蛋白钾的组合;
优选地,所述两性表面活性剂包括月桂酰两性基乙酸钠、椰油酰两性基乙酸钠、椰油酰两性基二乙酸二钠、月桂基甜菜碱、椰油基甜菜碱、椰油酰两性基羟丙基磺酸钠、椰油酰胺丙基甜菜碱、椰油酰胺丙基羟基磺基甜菜碱或月桂基羟基磺基甜菜碱中的任意一种或至少两种的组合;
优选地,所述两性表面活性剂为月桂酰两性基乙酸钠和月桂基羟基磺基甜菜碱的组合。
6.根据权利要求1-5任一项所述的洁面卸妆啫喱,其特征在于,所述阴离子表面活性剂包括月桂醇聚醚磺基琥珀酸酯二钠、甲基椰油酰基牛磺酸钠、椰油酰甲基牛磺酸牛磺酸钠、椰油酰氨基丙酸钠、C14-16烯烃磺酸钠、月桂基甘醇羧酸钠、月桂醇聚醚-6羧酸钠、月桂醇磷酸酯钾、椰油酰羟乙磺酸酯钠或月桂基葡萄糖羧酸钠中的任意一种或至少两种的组合;
优选地,所述阴离子表面活性剂为月桂基甘醇羧酸钠和月桂醇聚醚-6羧酸钠的组合;
优选地,所述非离子表面活性剂包括糖脂、癸基葡糖苷、辛基/癸基葡糖苷、月桂基葡糖苷、椰油基葡糖苷、庚基葡糖苷、泊洛沙姆184、泊洛沙姆188、PEG-6辛酸/癸酸甘油酯类、PEG-7辛酸/癸酸甘油酯类、PEG-8辛酸/癸酸甘油酯类、PEG-7甘油椰油酸酯、PEG-80失水山梨醇月桂酸酯、蔗糖月桂酸酯、蔗糖二月桂酸酯、蔗糖棕榈酸酯、蔗糖硬脂酸酯、蔗糖多硬脂酸酯、聚甘油-2癸酸酯、聚甘油-3癸酸酯、聚甘油-4癸酸酯、聚甘油-6辛酸酯、辛酸/癸酸甘油酯类聚甘油-10酯类、聚甘油-10月桂酸酯、聚甘油-10肉豆蔻酸酯、聚甘油-10油酸酯或聚甘油-10硬脂酸酯中的任意一种或至少两种的组合;
优选地,所述非离子表面活性剂为糖脂和聚甘油-10肉豆蔻酸酯的组合。
7.根据权利要求1-6任一项所述的洁面卸妆啫喱,其特征在于,所述皮肤调理剂包括氢化淀粉水解物、麦芽寡糖葡糖苷、木糖醇基葡糖苷、木糖醇、脱水木糖醇、PPG-10甲基葡糖醚、甲基葡糖醇聚醚-10、甲基葡糖醇聚醚-20、甘油葡糖苷、聚季铵盐-7、聚季铵盐-22、聚季铵盐-39、透明质酸钠、马来酸改性蓖麻油或C12-13醇乳酸酯中的任意一种或至少两种的组合;
优选地,所述皮肤调理剂为PPG-10甲基葡糖醚、聚季铵盐-7和马来酸改性蓖麻油的组合。
8.根据权利要求1-7任一项所述的洁面卸妆啫喱,其特征在于,所述洁面卸妆啫喱中还包括防腐剂;
优选地,所述防腐剂包括1,2-己二醇、1,2-戊二醇、对羟基苯乙酮、覆盆子酮、苯氧乙醇、乙基己基甘油或辛甘醇中的任意一种或至少两种的组合。
9.一种如权利要求1-8任一项所述的洁面卸妆啫喱的制备方法,其特征在于,所述制备方法包括如下步骤:
(1)将多元醇、氨基酸表面活性剂、两性表面活性剂、阴离子表面活性剂、非离子表面活性剂和水混合均匀,得到混合物;
(2)将所述混合物加热搅拌,分批次加入增稠剂,继续搅拌至分散均匀,降温加入皮肤调理剂、可选地防腐剂,搅拌均匀,过滤,得到所述洁面卸妆啫喱。
10.根据权利要求8所述的制备方法,其特征在于,步骤(2)中加热搅拌的温度为90-95℃;
优选地,所述降温的温度为45-50℃;
优选地,所述过滤的滤布孔径为80-120目。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410037043.0A CN117838565A (zh) | 2024-01-10 | 2024-01-10 | 一种洁面卸妆啫喱及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410037043.0A CN117838565A (zh) | 2024-01-10 | 2024-01-10 | 一种洁面卸妆啫喱及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117838565A true CN117838565A (zh) | 2024-04-09 |
Family
ID=90537975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410037043.0A Pending CN117838565A (zh) | 2024-01-10 | 2024-01-10 | 一种洁面卸妆啫喱及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117838565A (zh) |
-
2024
- 2024-01-10 CN CN202410037043.0A patent/CN117838565A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107213063B (zh) | 一种皙透亮白面膜及其制备方法 | |
CN108030764B (zh) | 一种双层卸妆液及其制备方法 | |
CN112675048B (zh) | 一种双层卸妆慕斯及其制备方法 | |
CN113768809B (zh) | 一种具有温和去角质功效的组合物及其制备方法与应用 | |
CN106256339A (zh) | 含植物性胶原蛋白的多功能洁面巾及其制造方法 | |
CN109106621B (zh) | 卸妆组合物及其制备方法和应用 | |
CN110339111A (zh) | 一种含矿物温泉的清洁组合物 | |
CN111184654A (zh) | 一种干湿两用洗面奶及其制备方法 | |
US10780029B2 (en) | Triphasic cleansing composition | |
CN110772437A (zh) | 快速吸油的免洗清洁组合物及制备方法和在发用湿巾中的应用 | |
CN112156023B (zh) | 一种卸妆凝胶及其制备方法 | |
CN114224764A (zh) | 一种适用于多种表活体系的沐浴乳组合物及其制备工艺 | |
CN111773141A (zh) | 一种洗卸二合一组合物及其制备方法 | |
CN109350561B (zh) | 一种稳定且有视觉化清洁功效的无泡沫洗面霜 | |
CN115006269B (zh) | 一种洗卸二合一组合物及其应用 | |
CN105534815A (zh) | 一种含有荷花活性成分的护肤组合物及其制备方法 | |
CN117838565A (zh) | 一种洁面卸妆啫喱及其制备方法 | |
CN110664687B (zh) | 护肤型净颜卸妆膏及其制备方法 | |
CN114917136A (zh) | 一种低残留的洁面组合物及其制备方法 | |
CN110496065A (zh) | 补水组合物 | |
CN109010105A (zh) | 一种多效合一的组合物及其制备方法和应用 | |
CN111481459B (zh) | 毛发化妆品组合物 | |
CN112641675B (zh) | 去黑头组合物、应用及去黑头磨砂洁肤膏 | |
CN115006270B (zh) | 一种具有清洁功效的面膜及其制备方法 | |
CN118058995A (zh) | 一种带自乳化润肤功效的卸妆凝露及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |